Video Experimental Relacionado

Updated: Sep 9, 2025

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Published on: July 5, 2024

Desarrollo de métodos para la síntesis de conjugados de ligandos-oligonucleótidos para aplicaciones de descubrimiento

Takashi Osawa¹

¹Graduate School of Pharmaceutical Sciences, The University of Osaka.

Chemical & pharmaceutical bulletin

|August 31, 2025

Resumen

Los investigadores están desarrollando nuevos métodos para sintetizar ácidos nucleicos artificiales, centrándose en los conjugados de ligando-oligonucleótido. Estos conjugados son prometedores para mejorar las terapias de oligonucleótidos y avanzar en el descubrimiento de fármacos.

Área de la Ciencia:

La bioquímica
Química medicinal
Descubrimiento de drogas

Sus antecedentes:

Las terapias de oligonucleótidos están ganando prominencia en la medicina.
El desarrollo de ácidos nucleicos artificiales funcionales es un foco de investigación global.
La síntesis de ácidos nucleicos artificiales a menudo requiere largas secuencias iniciales, lo que complica la optimización estructural.

Objetivo del estudio:

Abordar los desafíos en la optimización estructural de las terapias de oligonucleótidos.
Introducir investigaciones centradas en el desarrollo de reacciones utilizando oligonucleótidos como materiales de partida.
Destacar la importancia de los conjugados de ligando-oligonucleótido en la administración y el descubrimiento de fármacos.

Principales métodos:

Desarrollo de nuevas reacciones sintéticas utilizando oligonucleótidos como materiales de partida.
Investigación de las propiedades y aplicaciones de los conjugados de ligando-oligonucleótido.
Revisión de las investigaciones existentes y presentación de los trabajos de los autores en este ámbito.

Principales resultados:

Los conjugados de ligando-oligonucleótido muestran potencial como sistemas avanzados de administración de fármacos.
Estos conjugados pueden mejorar la eficacia de los oligonucleótidos terapéuticos.
También sirven como herramientas valiosas en el descubrimiento de medicamentos basados en la biblioteca codificada en ADN.

Conclusiones:

Los conjugados ligando-oligonucleótidos representan una estrategia prometedora para mejorar las terapias basadas en oligonucleótidos.
El desarrollo de métodos sintéticos eficientes es crucial para avanzar en este campo.
Esta investigación contribuye al creciente campo de las terapias con ácido nucleico artificial.

Palabras clave:

Biblioteca codificada por el ADN Conjugado de oligonucleótidos Terapia con oligonucleótidos

Más Videos Relacionados

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Videos de Conceptos Relacionados

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Complexometric Titration: Ligands

Complexometric Titration: Ligands

Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Phase II Conjugation Reactions: Overview

Phase II Conjugation Reactions: Overview

Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...

Labeling DNA Probes

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...